- €37.71bn
- €67.21bn
- €45.58bn
Annual cashflow statement for Bayer AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,022 | 4,166 | -2,942 | -2,546 | -3,595 |
| Depreciation | |||||
| Non-Cash Items | 795 | 521 | 1,898 | 1,562 | 1,366 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 255 | -4,094 | -3,859 | -433 | 5,369 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 5,128 | 7,096 | 5,117 | 7,366 | 5,925 |
| Capital Expenditures | -2,611 | -2,949 | -2,751 | -2,778 | -2,487 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 3,466 | 568 | -766 | 2,942 | 1,217 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 855 | -2,381 | -3,517 | 164 | -1,270 |
| Financing Cash Flow Items | -1,200 | -1,251 | -1,552 | -2,013 | -1,698 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -5,645 | -4,220 | -679 | -7,178 | -3,884 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 373 | 607 | 736 | 284 | 480 |